These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33977212)

  • 1. Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease.
    Brown MC; White MH; Friedberg R; Woods K; Childress K; Kulkarni M; Sidonio RF
    Res Pract Thromb Haemost; 2021 May; 5(4):e12513. PubMed ID: 33977212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
    Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
    Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin concentration and body mass index are determinants of plasma von Willebrand factor and factor VIII levels.
    Carter-Febres M; Fenchel M; Pomales J; Tarango C; Mullins ES
    Thromb Res; 2024 Aug; 240():109061. PubMed ID: 38870771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease.
    Biguzzi E; Siboni SM; le Cessie S; Baronciani L; Rosendaal FR; van Hylckama Vlieg A; Peyvandi F
    J Thromb Haemost; 2021 Jan; 19(1):96-106. PubMed ID: 32998182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():679-691. PubMed ID: 37204745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.
    Atiq F; Meijer K; Eikenboom J; Fijnvandraat K; Mauser-Bunschoten EP; van Galen KPM; Nijziel MR; Ypma PF; de Meris J; Laros-van Gorkom BAP; van der Bom JG; de Maat MP; Cnossen MH; Leebeek FWG;
    Br J Haematol; 2018 Jul; 182(1):93-105. PubMed ID: 29767844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients.
    Doshi BS; Rogers RS; Whitworth HB; Stabnick EA; Britton J; Butler RB; Obstfeld AE; Witmer CM
    J Thromb Haemost; 2019 Nov; 17(11):1838-1847. PubMed ID: 31350816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD.
    Atiq F; Schütte LM; Looijen AEM; Boender J; Cnossen MH; Eikenboom J; de Maat MPM; Kruip MJHA; Leebeek FWG
    Blood Adv; 2019 Dec; 3(24):4147-4154. PubMed ID: 31834934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.
    Bucciarelli P; Siboni SM; Stufano F; Biguzzi E; Canciani MT; Baronciani L; Pagliari MT; La Marca S; Mistretta C; Rosendaal FR; Peyvandi F
    J Thromb Haemost; 2015 Feb; 13(2):228-36. PubMed ID: 25425019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of current perioperative management with Haemate
    Hazendonk HCAM; Heijdra JM; de Jager NCB; Veerman HC; Boender J; van Moort I; Mathôt RAA; Meijer K; Laros-van Gorkom BAP; Eikenboom J; Fijnvandraat K; Leebeek FWG; Cnossen MH;
    Haemophilia; 2018 May; 24(3):460-470. PubMed ID: 29573506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand disease and aging: an evolving phenotype.
    Sanders YV; Giezenaar MA; Laros-van Gorkom BA; Meijer K; van der Bom JG; Cnossen MH; Nijziel MR; Ypma PF; Fijnvandraat K; Eikenboom J; Mauser-Bunschoten EP; Leebeek FW;
    J Thromb Haemost; 2014 Jul; 12(7):1066-75. PubMed ID: 24750783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease.
    Eising HP; Sanders YV; de Meris J; Leebeek FWG; Meijer K
    Haemophilia; 2018 Nov; 24(6):950-956. PubMed ID: 29989261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
    Delbrück C; Miesbach W
    Acta Haematol; 2019; 142(2):71-78. PubMed ID: 31085919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.